Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
Cristina Ruiz‐Ruiz, Francesco Calzaferri, Antonio G. Garcı́a
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
Tiffany D. Ricketts, Néstor Prieto‐Domínguez, Pramod S. Gowda, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 127
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity
Francesca Provenzano, Carola Torazza, Tiziana Bonifacino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15430-15430
Open Access | Times Cited: 19
A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists
Simran Soni, Mihir S. Lukhey, Baban S. Thawkar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4643-4656
Closed Access | Times Cited: 7
Inflamed brain: Targeting immune changes and inflammation for treatment of depression
Shinji Sakamoto, Xiaolei Zhu, Yuto Hasegawa, et al.
Psychiatry and Clinical Neurosciences (2021) Vol. 75, Iss. 10, pp. 304-311
Open Access | Times Cited: 39
P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
Judith Bockstiegel, Jonas Engelhardt, Günther Weindl
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Mechanisms of astrocytic and microglial purinergic signaling in homeostatic regulation and implications for neurological disease
Moawiah M. Naffaa
Exploration of neuroscience (2025)
Open Access
Drug Combination to Slow Down the Progression of Amyotrophic Lateral Sclerosis
Myriam Torres-Rico, Borja Marín-Rodríguez, Miriam Samira Arasmou-Idrovo, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation
Francesco Calzaferri, Paloma Narros‐Fernández, Ricardo de Pascual, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 2272-2290
Open Access | Times Cited: 24
Contribution of non-selective membrane channels and receptors in epilepsy
Claudia García‐Rodríguez, Iván Darío Bravo Tobar, Yorley Duarte, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107980-107980
Closed Access | Times Cited: 24
Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: potential broad-spectrum therapeutic targets against infectious diseases
Angamuthu Selvapandiyan, Niti Puri, Pankaj Kumar, et al.
FEMS Microbiology Reviews (2022) Vol. 47, Iss. 1
Closed Access | Times Cited: 18
The Gpx4NIKO Mouse Is a Versatile Model for Testing Interventions Targeting Ferroptotic Cell Death of Spinal Motor Neurons
Robert C. Evans, Liuji Chen, Ren Na, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 2, pp. 373-383
Open Access | Times Cited: 14
Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Jason C. O’Connor, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 5, pp. 401-418
Closed Access | Times Cited: 2
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10649-10649
Open Access | Times Cited: 17
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Rachael Bartlett, Diane Ly, Neil R. Cashman, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 451-467
Open Access | Times Cited: 11
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
Maria Carolina Bittencourt Gonçalves, Roberta Andrejew, Carolina Gubert
CNS Drugs (2022) Vol. 36, Iss. 8, pp. 787-801
Open Access | Times Cited: 11
Taurodeoxycholate ameliorates DSS-induced colitis in mice
Yunyun Zou, Aziz Ghaderpour, Bolormaa Munkhbileg, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110628-110628
Closed Access | Times Cited: 6
Src family kinases activity is required for transmitting purinergic P2X7 receptor signaling in cortical spreading depression and neuroinflammation
Lingdi Nie, Dongqing Ma, John P. Quinn, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
Cinzia Volonté, Susanna Amadio, Francesco Liguori, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis
André D. J. McKenzie, Taylor R. Garrett, Eryn L. Werry, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 10, pp. 1479-1490
Closed Access | Times Cited: 8
Synthetic molecules as P2X7 receptor antagonists: A medicinal chemistry update focusing the therapy of inflammatory diseases
João Carlos Martins Mafra, Núbia Boechat, Guilherme Pegas Teixeira, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175999-175999
Closed Access | Times Cited: 4
A Hybrid Approach Combining Shape-Based and Docking Methods to Identify Novel Potential P2X7 Antagonists from Natural Product Databases
Natiele Carla da Silva Ferreira, Lucas G. Viviani, Lauro M. Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 592-592
Open Access | Times Cited: 1
Ca2+ dysregulation in the pathogenesis of amyotrophic lateral sclerosis
Valentina Tedeschi, Tiziana Petrozziello, Agnese Secondo
International review of cell and molecular biology (2021), pp. 21-47
Closed Access | Times Cited: 10
Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease—A clinico-radiological and neuroscientific perspective
Freimut D. Juengling, Frank Wuest, Sanjay Kalra, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 7


ANALES RANM (2022) Vol. 139, Iss. 139(01)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top